Medicaid providers and suppliers have likely discovered this the hard way. A provider’s or supplier’s enrollment in the Medicaid program may be insufficient to assure that their provision of a covered and medically necessary...more
Check your mailboxes. AHCA is sending out postcards to existing Florida Medicaid providers (Providers) alerting them to upcoming changes in the Florida Medicaid program. These changes require Providers to pay certain of...more
To facilitate the provision of care during the pandemic, the federal government and many state governments enacted changes that encouraged physicians and other nonphysician practitioners (collectively, Practitioners) to use...more
Florida has been contemplating ways to increase patient access to care, especially in light of the COVID-19 pandemic and the anticipated increase in cases. Recognizing the accessibility of pharmacies, Florida is now...more
6/19/2020
/ Chronic Care Managment (CCM) ,
Clinical Laboratory Testing ,
Coronavirus/COVID-19 ,
Emergency Management Plans ,
Florida ,
Patient Access ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacist ,
Screening Procedures ,
Virus Testing
Facing unprecedented community spread of the 2019 Novel Coronavirus Disease (COVID-19), the Centers for Medicare and Medicaid Services (CMS) has provided additional guidance to a variety of health care providers that is...more
In an effort to preserve healthcare resources (e.g., personal protective equipment), limit potential contact with infected individuals, and free up healthcare practitioners to assist with those suffering from COVID-19,...more
Last summer The Centers for Medicare and Medicaid Services (CMS) solicited input on potential amendments to the federal Physician Self-Referral Law (the Stark Law)....more
3/28/2019
/ Anti-Kickback Statute ,
Centers for Medicare & Medicaid Services (CMS) ,
False Claims Act (FCA) ,
Fraud and Abuse ,
Health Care Providers ,
Medicaid ,
Medicare ,
Regulatory Agenda ,
Rulemaking Process ,
Self-Referral ,
Self-Referral Disclosure Protocol ,
Stark Law ,
Value-Based Payments
Throughout his presidential campaign, President Trump championed the need to allow the government to negotiate drug prices on behalf of the Medicare program. However, that third rail for pharmaceutical companies was not...more
5/22/2018
/ Competition ,
Drug Pricing ,
Generic Drugs ,
Life Sciences ,
Medicare Part D ,
Out-of-Pocket Expenses ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Reform ,
Trump Administration
President Trump has been clear in his intention to repeal the ACA. In fact, among President Trump’s first executive orders was one seeking to “minimize the economic burden” associated with the Patient Protection and...more
1/24/2017
/ Affordable Care Act ,
American Hospital Association ,
EHR ,
Employee Benefits ,
Employer Mandates ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Hospitals ,
Meaningful Use ,
Regulatory Oversight ,
Repeal ,
Trump Administration
As we welcome the new year and its endless possibilities, we also welcome some new Anti-Kickback Statute safe harbors and concomitant business possibilities. In December, the U.S. Department of Health and Human Services...more
The American Hospital Association, after having been “nice” all year, penned its letter to Santa Claus with its wish list for Christmas. Its four page letter (actually addressed to President-Elect Donald Trump at 1717...more
1/10/2017
/ ACOs ,
Affordable Care Act ,
American Hospital Association ,
Anti-Kickback Statute ,
Children's Health Insurance Program (CHIP) ,
Department of Justice (DOJ) ,
EHR ,
Federal Trade Commission (FTC) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Home Health Agencies ,
Hospitals ,
Meaningful Use ,
Medical Malpractice ,
Medical Reimbursement ,
Medicare ,
Medicare Part A ,
Medicare Part B ,
Mergers ,
Patient Safety ,
Regulatory Oversight ,
Safe Harbors ,
Section 340B ,
Stark Law ,
Telehealth ,
Trump Administration